Company news
Nuvo Pharmaceuticals Inc news in 2016
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2016, newest first.
Nuvo Pharmaceuticals(TM) Inc. Appoints Jesse Ledger as President
November 16, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 Third Quarter Results
November 10, 2016
Nuvo Pharmaceuticals(TM) Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial for Treatment of Acute Ankle Sprains
October 17, 2016
Nuvo Pharmaceuticals(TM) Inc. Appoints New Chief Financial Officer
September 1, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 Second Quarter Results
August 10, 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in the E.U., Canada and Australia
July 13, 2016
Nuvo Pharmaceuticals, Anti-Inflammatory Medicine with Less Side Effects, CEO Clip Video
June 24, 2016
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
June 7, 2016
Nuvo Pharmaceuticals(TM) Announces 2016 First Quarter Results
May 11, 2016
Nuvo Pharmaceuticals(TM) Inc. announces appointment of Vice President, Business Development
April 4, 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Results from European Ankle Sprain Study with Pennsaid® 2%
March 7, 2016
Nuvo Research® Inc. Completes Reorganization into Two Publicly Traded Companies
March 1, 2016
Nuvo Research® Inc. Obtains Final Court Order Approving Reorganization into Two Publicly-Traded Companies
February 24, 2016
Nuvo Research® Shareholders Approve Proposed Reorganization into Two Separate Public Companies
February 18, 2016
Nuvo Research® Announces 2015 Fourth Quarter & Year-End Results
February 17, 2016
Nuvo Research® and Horizon Pharma plc Extend Term of Manufacturing Agreement
February 8, 2016
Nuvo Research® Provides Estimated Revenue for the 2015 Fourth Quarter and Year End
January 21, 2016